ArticleJournal of translational medicine2023

Safety and efficacy of co-administration of CD19 and CD22 CAR-T cells in children with B-ALL relapse after CD19 CAR-T therapy.

Wenjie Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.